Modulation of Several Downstream Cascades Served by Enzymes in the Pathogenesis of Stroke

Interruption of blood circulation to the brain, leading to neuronal destruction and functional impairment, is an attribute of a stroke, a major contributor to death and disability worldwide. The enzymes associated with oxidative assault, inflammation, and tissue repair are all crucial in understanding the pathophysiology of stroke. Oxygen deprivation during a stroke causes enzyme activation, which in turn causes the production of reactive oxygen species (ROS) and oxidative stress. ROS, generated by nicotinamide adenine dinucleotide phosphate and xanthine oxidases, exacerbates brain cell injury by inducing lipid peroxidation, DNA damage, and protein oxidation. Inflammatory mediators are produced when cyclooxygenase (COX), lipoxygenase (LOX), and matrix metalloproteinases (MMPs) are activated. COX enzymes generate prostaglandins, which promote inflammation and contribute to brain injury. LOX enzymes produce leukotrienes and other lipid mediators that exacerbate inflammation and tissue damage. MMPs, particularly MMP-9, contribute to blood-brain barrier disruption and inflammatory cell infiltration. Excitotoxicity, the pathological process involving excessive stimulation of glutamate receptors, contributes to neuronal death in stroke. Excitotoxic signaling is accomplished by glutamate receptors like N-methyl-D-aspartate (NMDA) and AMPA receptors, and glutamate-activated enzymes and GSs regulate glutamate metabolism. Tissue remodeling and removal of cellular waste aid tPA and MMPs. Patients experiencing an ischemic stroke are given thrombolytic therapy with tPA. In addition, MMP activation promotes extracellular matrix (ECM) disintegration, which aids in tissue repair and functional restoration. Enzyme research into stroke has provided new targets for treatment. In cases of ischemic stroke, thrombolytic therapy like tPA injection tries to improve blood flow. Stroke patients’ brain damage can be reduced and their outcomes improved by blocking inflammatory enzymes, including COX and MMPs. Finally, enzymes are involved in many different aspects of stroke, including oxidative assault, inflammation, and tissue healing. Understanding enzymes’ intricate role in stroke pathogenesis provides opportunities to discern avenues for intervention that enhance patient outcomes.